Soleno Therapeutics, Inc.Soleno Therapeutics, Inc.Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.

No trades
See on Supercharts

Price target

74.250.000.00%
The 8 analysts offering 1 year price forecasts for SLNO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to SLNO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SLNO EPS for the last quarter is −1.83 USD despite the estimation of −0.61 USD. In the next quarter EPS is expected to reach −1.03 USD. Track more of Soleno Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Soleno Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Soleno Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SLNO price target is 74.25 USD with a max estimate of 93.00 USD and a min estimate of 67.00 USD. Check if this forecast comes true in a year, meanwhile watch Soleno Therapeutics, Inc. stock price chart and keep track of the current situation with SLNO news and stock market news.
We've gathered opinions of 8 analysts rating SLNO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.